Saving your money for next purchases
Eculizumab Injection
This drug is the world’s first approved C5 complement inhibitor. It was approved in China in 2018 and passed the application for change of origin of the raw solution in August this year. It is used to treat paroxysmal nocturnal hemoglobinuria and atypical hemolytic uremic syndrome in adults and children.
Share:
Products
Our offers
Delivery – when you want and anywhere
A huge selection of best products
Health Classification
Let us work together to protect precious health
